Alcresta Therapeutics, INC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersWaltham, MA
US patents20
SAM.gov UEIYFUTGG4USLE7
CAGE code8CW10
Incorporated inDE
- enzyme products
- enteral nutrition
- address fat malabsorption
- microbead/enzyme technology
- rare diseases
- absorption
- enterally fed
Named on the company’s own website, read JUL 29, 2026
What they make
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
20 US patents granted 2017–2024, 13 of them in the five years to SEP 2025.
Pharmaceuticals 20
- Methods, compositions, and devices for supplying dietary fatty acid needsUS 12,178,785 · granted DEC 31, 2024
- Methods, compositions, and devices for supplying dietary fatty acid needsUS 12,178,784 · granted DEC 31, 2024
- Devices and methods for the preparation of a nutritional formulaUS 12,137,713 · granted NOV 12, 2024
- Methods, compositions, and devices for supplying dietary fatty acid needsUS 12,059,391 · granted AUG 13, 2024
- Methods, compositions, and devices for supplying dietary fatty acid needsUS 11,998,511 · granted JUN 4, 2024
Newest 5 shown · Granted to Alcresta Therapeutics, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Alcresta Therapeutics, INC | Waltham | MA | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.